Abe, M., Tsushima, K., Sakayori, M., Suzuki, K., Ikari, J., Terada, J., & Tatsumi, K. (2018). Utility of nintedanib for severe idiopathic pulmonary fibrosis: A single-center retrospective study. Drug Des Devel Ther.
Style de citation ChicagoAbe, Mitsuhiro, Kenji Tsushima, Masashi Sakayori, Kenichi Suzuki, Jun Ikari, Jiro Terada, et Koichiro Tatsumi. "Utility of Nintedanib for Severe Idiopathic Pulmonary Fibrosis: A Single-center Retrospective Study." Drug Des Devel Ther 2018.
Style de citation MLAAbe, Mitsuhiro, et al. "Utility of Nintedanib for Severe Idiopathic Pulmonary Fibrosis: A Single-center Retrospective Study." Drug Des Devel Ther 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.